Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026)
Intuitive Surgical (ISRG) posted quarterly Cash from Financing Activities of -$287.9 million for Q2 2026, down 94.79% year-over-year from -$5.5 billion in Q2 2025, and up 78.73% quarter-over-quarter from -$1.4 billion in Q1 2026.
Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$287.9 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 94.79% year-over-year to -$287.9 million; the TTM figure through Jun 2026 stood at -$3.6 billion (down 1434.79% YoY), while the FY2025 annual figure was -$2.4 billion, down 1666.67% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$287.9 million, up from -$1.4 billion in the prior quarter.
- The five-year high for Cash from Financing Activities was $98.2 million in Q3 2024, with the low at -$1.8 billion in Q3 2025.
- The 5-year median for Cash from Financing Activities is -$173.8 million (2022), against an average of -$373.0 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 5280.11% in 2022, then soared 256.83% in 2024.
- Intuitive Surgical's Cash from Financing Activities stood at -$963.5 million in 2022, then soared by 96.73% to -$31.5 million in 2023, then jumped by 256.83% to $49.4 million in 2024, then plunged by 378.34% to -$137.5 million in 2025, then tumbled by 109.38% to -$287.9 million in 2026.
- Business Quant data shows ISRG's Cash from Financing Activities at -$287.9 million in Q2 2026, -$1.4 billion in Q1 2026, and -$137.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -67.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -287.90 Mn |
| Jun 30, 2026 | -287.90 Mn |
| Mar 31, 2026 | -1.35 Bn |
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | -137.50 Mn |
| Dec 31, 2025 | -137.50 Mn |
| Sep 30, 2025 | -1.84 Bn |
| Sep 30, 2025 | -1.84 Bn |
| Jun 30, 2025 | -147.80 Mn |
| Jun 30, 2025 | -147.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Mar 31, 2024 | -46.70 Mn |